Multi-stakeholder contribution to the identification of a core outcome set and measurements in implant dentistry (ID-COSM initiative) using the Delphi methodology.

AIM To obtain input from multiple stakeholders and generate agreement on essential outcomes in implant dentistry using the Delphi methodology and incorporate them into an international consensus defining a core outcome set. MATERIALS AND METHODS Candidate outcomes in implant dentistry were generated from scientific evidence through five commissioned systematic reviews and from people with lived experience in dental implants (PWLE) through four international focus groups. A steering committee identified stakeholders among representatives from dental professionals, industry-related experts and PWLE. Participants underwent a three-round Delphi survey using a multi-stakeholder approach; they assessed candidate outcomes and additional outcomes identified in the first Delphi round. The process followed the COMET methodology. RESULTS From the 665 potential outcomes identified in the systematic reviews and 89 in the PWLE focus group, the steering committee selected 100 and organized them into 13 categories, to be included in the first-round questionnaire as candidate outcomes. A total of 99 dental experts, 7 dental-industry-related experts and 17 PWLE participated in the first round, and 11 additional outcomes were added to the second round. There was no attrition between the first and second rounds, where 61 (54.9%) outcomes exceeded the pre-established threshold of agreement. PWLE and experts participated in the third round that applied "a priori" standard filters to distil a list of candidate essential outcomes. CONCLUSION This Delphi study utilized a standardized, transparent and inclusive methodology and preliminarily validated 13 essential outcomes organized into four core areas. These results informed the final stage of the ID-COSM consensus.

[1]  M. Sanz,et al.  Involving people with lived experience in developing a core outcome set for implant dentistry research. The Impant Dentistry-Core Outcomes Sets and Measures (ID-COSM) project. , 2023, Journal of clinical periodontology.

[2]  P. Papapanou,et al.  Relevant domains, core outcome sets and measurements for implant dentistry clinical trials: The Implant Dentistry Core Outcome Set and Measurement (ID-COSM) international consensus report. , 2023, Clinical oral implants research.

[3]  B. Pjetursson,et al.  Rehabilitation of full-arch edentulism with fixed or removable dentures retained by root-form dental implants: A systematic review of outcomes and outcome measures used in clinical research in the last 10 years. , 2022, Clinical oral implants research.

[4]  E. Montero,et al.  Bone preservation or augmentation simultaneous with or prior to dental implant placement: A systematic review of outcomes and outcome measures used in clinical trials in the last 10 years. , 2022, Journal of clinical periodontology.

[5]  I. Sailer,et al.  Single and partial tooth replacement with fixed dental prostheses supported by dental implants: a systematic review of outcomes and outcome measures used in clinical trials in the last 10 years. , 2022, Journal of clinical periodontology.

[6]  J. Derks,et al.  Prevention and management of peri-implant mucositis and peri-implantitis: a systematic review of outcome measures used in clinical studies in the last 10 years. , 2022, Journal of clinical periodontology.

[7]  D. Thoma,et al.  Outcome measures and methods of assessment of soft tissue augmentation interventions in the context of dental implant therapy: A systematic review of clinical studies published in the last 10 years. , 2022, Journal of clinical periodontology.

[8]  H. Ashrafian,et al.  Investigating the Implementation of SMS and Mobile Messaging in Population Screening (the SIPS Study): Protocol for a Delphi Study , 2021, JMIR research protocols.

[9]  M. Suarez‐Almazor,et al.  Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative. , 2021, Seminars in arthritis and rheumatism.

[10]  David W. Johnson,et al.  Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease. , 2021, Kidney international.

[11]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. , 2021, Journal of clinical epidemiology.

[12]  M. Sanz,et al.  Delphi Project on the trends in Implant Dentistry in the COVID‐19 era: Perspectives from Latin America , 2021, Clinical oral implants research.

[13]  S. Purkayastha,et al.  Investigating the Ethical and Data Governance Issues of Artificial Intelligence in Surgery: Protocol for a Delphi Study , 2020, JMIR research protocols.

[14]  R. Jung,et al.  European Association for Osseointegration Delphi study on the trends in Implant Dentistry in Europe for the year 2030. , 2019, Clinical oral implants research.

[15]  W. Abhayaratna,et al.  Patients’ Attitudes and Experiences of Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Synthesis , 2018, Arthritis care & research.

[16]  Jane M Blazeby,et al.  Core Outcome Set-STAndards for Development: The COS-STAD recommendations , 2017, PLoS medicine.

[17]  P. Tugwell,et al.  Core Outcome Set–STAndards for Reporting: The COS-STAR Statement , 2016, PLoS medicine.

[18]  F. Graziani,et al.  EFP Delphi study on the trends in Periodontology and Periodontics in Europe for the year 2025. , 2016, Journal of clinical periodontology.

[19]  D. Altman,et al.  Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey , 2016, Trials.

[20]  M. Pangalos,et al.  Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework , 2014, Nature Reviews Drug Discovery.

[21]  H. Shimura,et al.  Research and development productivity map: visualization of industry status , 2014, Journal of clinical pharmacy and therapeutics.

[22]  S. Masuda,et al.  A lesson from Japan: research and development efficiency is a key element of pharmaceutical industry consolidation process. , 2014, Drug discoveries & therapeutics.

[23]  P. Williamson,et al.  Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies , 2011, PLoS medicine.

[24]  N. Dalkey,et al.  An Experimental Application of the Delphi Method to the Use of Experts , 1963 .